Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer

Anishka D'Souza1, Darcy Spicer1, Janice Lu2

  • 1USC Norris Comprehensive Cancer Center, 1441 Eastlake Avenue, Los Angeles, CA, 90033, USA.

Insights

Treatment for metastatic hormone receptor-positive breast cancer now includes CDK4/6 inhibitors, improving progression-free survival. Further research explores PI3K and mTOR inhibitors for endocrine resistance, guiding optimal therapy sequencing.

Area of Science:

  • Oncology
  • Endocrinology
  • Pharmacology

Background:

  • Hormone receptor-positive breast cancer (HR+ BC) is often treated with endocrine therapy.
  • Endocrine resistance is a significant challenge in managing metastatic HR+ BC.
  • Novel therapeutic strategies are needed to overcome endocrine resistance.

Purpose of the Study:

  • To review current treatment strategies for metastatic HR+ BC.
  • To discuss the role of newer agents like CDK4/6 inhibitors.
  • To explore the potential of PI3K and mTOR inhibitors in endocrine-resistant settings.

Main Methods:

  • Literature review of clinical trials and studies.
  • Analysis of treatment outcomes for various drug combinations.
  • Evaluation of factors influencing therapeutic sequencing.

Main Results:

  • CDK4/6 inhibitors have demonstrated significant improvements in progression-free survival.
  • PI3K and mTOR inhibitors are being investigated as subsequent lines of therapy.
  • Optimal sequencing depends on patient-specific factors.

Conclusions:

  • CDK4/6 inhibitors represent a major advancement in metastatic HR+ BC treatment.
  • Targeted therapies like PI3K and mTOR inhibitors offer promise for endocrine resistance.
  • Personalized treatment sequencing is crucial for maximizing patient benefit.

Related Concept Videos

Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
68.2K
Intracellular Hormone Receptors01:08

Intracellular Hormone Receptors

Lipid-soluble hormones diffuse across the plasma and nuclear membrane of target cells to bind to their specific intracellular receptors. These receptors act as transcription factors that regulate gene expression and protein synthesis in the target cell
59.4K
Types of Hormones02:13

Types of Hormones

Hormones can be classified into three main types based on their chemical structures: steroids, peptides, and amines. Their actions are mediated by the specific receptors they bind to on target cells.
83.8K